1,3,2-Dioxaborolane, 2-[2-[(3,4-dichlorophenyl)methoxy]phenyl]-4,4,5,5-tetramethyl-, 95%, 100mg

Sapitinib, 99.93%, 5mg

Éster propílico del ácido 4-hidroxibenzoico, mínimo 98 %, Ph. Eur., USP, 250 g, envase de plástico.

4,4,5,5-Tetramethyl-2-(naphthalen-1-ylmethyl)-1,3,2-dioxaborolane, 98%, 250mg

Botes recolectores de seguridad Safety Can, 7,5 l, 1 pieza

Methyl 5-bromo-4-methoxypicolinate, 98.0%, 5g

2-(Trifluoromethyl)benzyl chloride, 97.0%, 1g

2-Sulfobenzoic acid cyclic anhydride, 95.0%, 5g

5-Methoxy-2-methylpyrimidine, 97%, 250mg

tert-Butyl 1-(hydroxymethyl)-2-oxa-5-azabicyclo[2.2.1]heptane-5-carboxylate, 97%, 1g

2-Bromo-5-Fluoroterephthalic acid, 95+%, 1g

N-(2-METHOXY-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)PROPANE-1-SULFONAMIDE, 95%, 250mg

(4-METHOXYTETRAHYDRO-2H-PYRAN-4-YL)METHANAMINE HCL, 95.0%, 250mg